Myriad Genetics, Inc. · NASDAQ:MYGN
Barclays PLC's stake in Myriad Genetics, Inc. fell to 4.23% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 12, 2025
Barclays PLC's stake in Myriad Genetics, Inc. fell to 4.23%, 3,939,238 shares, as a passive investor on Sep 30, 2025. Filed Nov 12, 2025 (Schedule 13G/A).
- Stake
- 4.23%
- Shares
- 3,939,238
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Barclays PLC | 4.23% | 3,939,238 |
Source
Related
- Myriad Genetics, Inc.
- Barclays PLC
- Myriad Genetics, Inc. shareholders
- Schedule 13G · Barclays PLC · Aug 12, 2025
- Form 4 · Wheeler Benjamin Richard · Sep 22, 2026
- Form 4 · Sikri Vishal · Sep 17, 2026
- Form 4 · Fox Jennifer Lynne · Sep 8, 2026
- Schedule 13G · BlackRock Portfolio Management LLC · Sep 4, 2026
- Form 4 · Wheeler Benjamin Richard · Aug 17, 2026